This is the authors' abstract. We don't add key points for this paper.
A subset of eukaryotic tRNAs is methylated in the anticodon loop, forming 3-methylcytosine (m 3 C) modifications. In mammals, the number of tRNAs containing m 3 C modifications has been expanded to include mitochondrial (mt) tRNA-Ser-UGA and mt-tRNA-Thr-UGU. However, whereas the enzymes catalyzing m 3 C formation in nuclear-encoded tRNAs have been identified, the proteins responsible for m 3 C modification in mt-tRNAs are unknown. Here, we show that m 3 C formation in human mt-tRNAs is dependent upon the methyltransferase-Like 8 (METTL8) enzyme. We find that METTL8 is a mitochondria-associated protein that interacts with mitochondrial seryl-tRNA synthetase, as well as with mt-tRNAs containing m 3 C. We demonstrate that human cells deficient in METTL8 exhibit loss of m 3 C modification in mt-tRNAs, but not nuclear-encoded tRNAs. Consistent with the mitochondrial import of METTL8, the formation of m 3 C in METTL8-deficient cells could be rescued by re-expression of WT METTL8, but not by a METTL8 variant lacking the N-terminal mitochondrial localization signal. Notably, we found METTL8-deficiency in human cells causes alterations in the native migration pattern of mt-tRNA-Ser-UGA, suggesting a role for m 3 C in tRNA folding. Altogether, these findings demonstrate that METTL8 is required for m 3 C formation in mt-tRNAs and uncover a potential function for m 3 C modification in mitochondrial tRNA structure.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lentini et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: